Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jenny V. Garmendia"'
Autor:
Jenny V. Garmendia, Juan B. De Sanctis
Publikováno v:
Immuno, Vol 1, Iss 11, Pp 174-193 (2021)
NK cells are lymphocytes involved in the innate and adaptative immune response. These cells are located in peripheral blood and tissues with ample functions, from immune vigilant to tolerogenic reactions. In the endometrium, NK cell populations vary
Autor:
Danuta Radzioch, J. B. De Sanctis, Marian Hajduch, Jenny V. Garmendia, Dolores Moreno, Alexis Garcia
Publikováno v:
Gaceta Médica de Caracas. 128:7-22
Al final del 2019, un nuevo patógeno, el coronavirus SARS-CoV2, fue identificado. El virus ha infectado a más de 30 millones de personas en el mundo entero con una letalidad cercana al 5 %. El SARS-CoV2 es un ARN virus. El genoma viral contiene 29
Autor:
Marian Hajduch, Nicolas E. Bianco, Michael Mijares, Gricelis Martínez, Maria Johanna Peña, Juan B. De Sanctis, I. Blanca, Alexis Garcia, Daniela Cerezo-Wallis, Camilo Di Giulio, Danuta Radzioch, Jenny V. Garmendia
Publikováno v:
Gaceta Médica de Caracas. 128:290-295
El cáncer es una enfermedad compleja en el cual se han utilizado numerosos tratamientos. El mayor avance en tratamiento ha sido el uso de inhibidores de puntos de control, disminuyendo la carga tumoral. La esperanza de vida de los pacientes con cán
Autor:
María Bravo García-Morato, Hugh T. Reyburn, Miriam Simón-Fuentes, Ane Calvo Apalategi, Jenny V. Garmendia, Ángeles Domínguez-Soto, Teresa del Rosal Rabes, Luz Yadira Bravo-Gallego, Ana Méndez Echevarría, Alfonso Blázquez Moreno, Eduardo López-Granados, Rebeca Rodríguez Pena
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
14 p.-5 fig.-5 tab.
Supported by grants SAF2014-58752-R and SAF2017-83265-R (to H.T.R.), SAF2017-83785-R (to A.D.-S.; MINECO/AEI/FEDER, UE), and a PhD studentship to A.B.M. (MINECO, SVP-2014-068263). E.L.-G. has grants from the Spanish Associati
Supported by grants SAF2014-58752-R and SAF2017-83265-R (to H.T.R.), SAF2017-83785-R (to A.D.-S.; MINECO/AEI/FEDER, UE), and a PhD studentship to A.B.M. (MINECO, SVP-2014-068263). E.L.-G. has grants from the Spanish Associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53457c0479a8e260d784abf0b9693b35
http://hdl.handle.net/10261/179720
http://hdl.handle.net/10261/179720
Autor:
De Sanctis Jb, Jenny V. Garmendia
Publikováno v:
Recent Patents on Inflammation & Allergy Drug Discovery. 9:46-53
The use of vaccines in pregnant, immunocompromised or chronic diseases patients has been widely discussed in the literature recently. Vaccines continue to be a safe and effective method to induce or recall immune response to several infective agents
Publikováno v:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery. 8:60-66
Metabolic syndrome (MetS) is a syndrome that involves at least three disorders dyslipidemia, insulin resistance, obesity and/or hypertension. MetS has been associated with several chronic diseases in the adulthood; however, in the recent years, the s
Autor:
Alexis Garcia, Juan B. De Sanctis, Carlos Tálamo, Joana Martin-Rojo, Nancy Larocca, Olga Velasquez, Jenny V. Garmendia, Dolores Moreno
Publikováno v:
Biomedical Papers. 157:374-378
Background. One of the gene polymorphisms often studied in asthmatic patients is the β2 adrenergic receptor (ADRβ2). Even though in the Venezuelan Mestizo population there is a high incidence of asthma, there are no direct reports of ADRβ2 gene po
Publikováno v:
Recent Patents on Biomarkers. 3:137-144
Autor:
De Sanctis Jb, Jenny V. Garmendia
Publikováno v:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery. 6:218-223
Endometriosis is an inflammatory disease characterized by the presence of endometrial glandular epithelial and stromal cells growing in the extra-uterine environment. The disease affects: ovarian function, oocyte quality, embryo development and impla
Publikováno v:
Recent Patents on Inflammation & Allergy Drug Discovery. 5:178-183
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized mainly by pulmonary airflow limitation that is not fully reversible. New different pharmacological approaches to decrease inflammation of the airways an